Patent · US Active

Processes for preparing JAK inhibitors and related intermediate compounds

US8410265B2 · kind B2 · utility

112Cited by
3References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2010
Grant dateApr 2, 2013
Priority date
Expiry dateAug 7, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines of Formula III, and related synthetic intermediate compounds. The chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines are useful as inhibitors of the Janus Kinase family of protein tyrosine kinases (JAKs) for treatment of inflammatory diseases, myeloproliferative disorders, and other diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.